[1]
|
Pauling, L., Itano, H.A., Singer, S.J. and Wells, I.G. (1948) Sickle-Cell Anemia, a Molecular Disease. Science, 110, 543-548. https://doi.org/10.1126/science.110.2865.543
|
[2]
|
Saiki, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H. and Arnheim, N. (1985) Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia. Science, 230, 1350-1352. https://doi.org/10.1126/science.2999980
|
[3]
|
Labie, D. (2009) La drépanocytose est de moins en moins monogénique. Hématologie, 15, 98-99. https://doi.org/10.1684/hma.2009.0309
|
[4]
|
Hauhouot-Attoungbré, M.L., Yapi, A., N’guessan-Edjeme, A., Yayo, E. and Monnet, D. (2005) Etude du métabolisme des dérives protidiques chez le drépanocytaire homozygote ssFA2 en phase stationnaire, 29, 5-6.
|
[5]
|
Rees, D.C., Williams, T.N. and Gladwin, M.T. (2010) Sickle-Cell Disease. The Lancet, 376, 2018-2031. https://doi.org/10.1016/S0140-6736(10)61029-X
|
[6]
|
Djembo-Taty, M., Tchiloemba, M., Galacteros, F., Rosa, J. and Lissouba, P. (1986) Etude épidémiologique des hémoglobinopathies au Congo chez 2257 nouveau-nés. Nouvelle Revue Française d’hématologie, 28, 249-251.
|
[7]
|
Mabiala-Babela, J.R., Nkanza-Kaluwako, T., Ganga-Zandzou, P.S., Nzingoula, S. and Senga, P. (2005) Causes d’hospitalisation des enfants drépanocytaires: Influence de l’age (CHU de Brazzaville, Congo). Bulletin de la Société de Pathologie Exotique, 98, 392-393.
|
[8]
|
Ngolet, L.O., Okouango, J.D., Ntsiba, H. and Elira Dokekias, A. (2017) Complications chroniques du sujet drépanocytaire adulte à Brazzaville. Health Sciences and Disease, 18, 56-59.
|
[9]
|
Cisse, R., Wandaogo, A., Tapsoba, T.L., Chateil, T.F., Ouiminga, R.M. and Diard, F. (1998) Apport de l’imagerie médicale dans les manifestations ostéo-articulaires de la drépanocytose chez l’enfant. Médecine d'Afrique Noire, 45, 220-224.
|
[10]
|
Platt, O., Branbilla, D.J. and Mosse, W. (1994) Mortality in Sickle Cell Disease: Life Expectancy and Risks Factors for Early Death. The New England Journal of Medicine, 330, 1639-1644. https://doi.org/10.1056/NEJM199406093302303
|
[11]
|
Clostre, F. (1993) Physiopathologie de la drépanocytose. Objectif Médical, 121, 37-43.
|
[12]
|
Pham, P.T.T., Pham, P.C.T. and Wilkinson, A.H. (2000) Renal Abnormalities in Sickle Cell Disease. Kidney International, 57, 1-8. https://doi.org/10.1046/j.1523-1755.2000.00806.x
|
[13]
|
Rahimi, Z., Merat, A., Haghshenass, M., Madani, H., Rezaei, M. and Nagel, R.L. (2006) Plasma Lipids in Iranians with Sickle Cell Disease: Hypocholesterolemia in Sickle Cell Anemia and Increase of HDL-Cholesterol in Sickle Cell Trait. Clinica Chimica Acta, 365, 217-220. https://doi.org/10.1016/j.cca.2005.08.022
|
[14]
|
Ephraim, R.K.D., Adu, P., Ake, E., Agbodzakey, H., Adoba, P., Cudjoe, O. and Agoni, C. (2016) Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis. Journal of Lipids, 2016, Article ID: 7650530. https://doi.org/10.1155/2016/7650530
|
[15]
|
Gueye Tall, F., Ndour, E.H.M., Cissé, F., Gueye, P.M., Ndiaye Diallo, R., Diatta, A., Lopez Sall, P. and Cissé, A. (2014) Perturbations de paramètres lipidiques au cours de la drépanocytose. Revue CAMES SANTE, 2, 35-41.
|
[16]
|
Aleluia, M.M., da Guarda, C.C., Santiago, R.P., Fonseca, T.C.C., Neves, F.I., de Souza, R.Q., Gonçalves, M.S., et al. (2017) Association of Classical Markers and Establishment of the Dyslipidemic Sub-Phenotype of Sickle Cell Anemia. Lipids in Health and Disease, 16, 74. https://doi.org/10.1186/s12944-017-0454-1
|
[17]
|
Shores, J., Peterson, J., Vander Jagt, D. and Glew, R.H. (2003) Reduced Cholesterol Levels in African-American Adults with Sickle Cell Disease. Journal of the National Medical Association, 95, 813-817.
|
[18]
|
Seixas, M.O., Rocha, L.C., Carvalho, M.B., Menezes, J.F., Lyra, I.M., Nascimento, V.M., Goncalves, M.S., et al. (2010) Levels of High-Density Lipoprotein Cholesterol (HDL-C) among Children with Steady-State Sickle Cell Disease. Lipids in Health and Disease, 9, 91. https://doi.org/10.1186/1476-511X-9-91
|
[19]
|
Monnet, D. and Yapo, A.E. (1993) Intérêt clinique du dosage de la protéine C-reactive, de l’alpha-glycoprotéine acide et de la transferrine au cours de la drépanocytose homozygote. Bulletin de la société de pathologie Exotique, 86, 282-285.
|
[20]
|
Benjamin, L.J. and Rouaud, C. (1985) Bichemical and Cellular Alterations in Sickle Cell Anemia Crisis Markers and Therapeutic Monitors. INSERM, 141, 451-454.
|
[21]
|
Tshibumbu, E., Manya, D., Semakuba, B., Kibulu, J. and Ndibualonji, V. (2019) Influence de la drepanocytose sur les bilans lipidique et azote a lubumbashi. American Journal of Innovative Research & Applied Sciences, 9, 39-44.
|
[22]
|
Monnet, D., Edjeme, N.E., Ndri, K., Hauhouot-Attoungbre, M.L., Ahibo, H. and Sangare, A. (2002) La lipoprotéine (a) et les protéines de la phase aiguë de l’inflammation an cours de la crise drépanocytaire homozygote. Annales de Biologie Clinique, 60, 101-103.
|
[23]
|
Mokondjimobe, E., Ovono-Abessolo, F., Gombet, T., Guie, G., Ngou-Milama, E. and Parra, H.J. (2012) Lipid, Lipoproteins and Atherogenesis Profiles in Sickle Cell Disease among Central African Patients. Annales de Biologie Clinique, 70, 183-188. https://doi.org/10.1684/abc.2012.0687
|
[24]
|
Ballas, S.K. and Marcolina, M.J. (2006) Hyperhemolysis during the Evolution of Uncomplicated Acute Painful Episodes in Patients with Sickle Cell Anemia. Transfusion Complication, 46, 105-110. https://doi.org/10.1111/j.1537-2995.2006.00679.x
|
[25]
|
Mounkaila, B., Oumarou Hamido, K., Garba, M., AbaBdoulaye Maiga, R., AKakpona, S.A. and Sanogo, I. (2015) Hémolyse chronique des sujets drépanocytaires SS et SC en phase stationnaire: étude comparative au centre national de référence de la drépanocytose à Niamey. Revue CAMES Santé, 3, 25-29.
|
[26]
|
Njoku, O.U., Alumunan, E.O. and Nwanjoh, J. (1996) Serum Lipids, ABO Blood Group and Sickle Cell Disease. Indian Journal of Physiology and Pharmacology, 40, 171-174.
|
[27]
|
Nagose, V. and Rathod, S. (2018) Hematological Profile of Sickle Cell Anemia Subjects in Central India: A Cross-Sectional Analysis. Annals of Pathology and Laboratory Medicine, 5, A87-A91. https://doi.org/10.21276/APALM.1694
|
[28]
|
Antwi-Boasiako, C., Ekem, I., Abdul-Rahman, M., Sey, F., Doku, A., Dzudzor, B. and Aryee, R. (2018) Hematological Parameters in Ghanaian Sickle Cell Disease Patients. Journal of Blood Medicine, 9, 203-209. https://doi.org/10.2147/JBM.S169872
|
[29]
|
Diop, S., Koffi, G., N’dahtle, Allangba, O., Aka Adjo, M.A. and Sangaré, A. (1997) Profil Infectieux chez les Drépanocytaires. Bulletin de la Société de pathologie exotique, 90, 339-341.
|
[30]
|
Elira Dokekias, A. (1994) Etude analytique des facteurs d’aggravation de la maladie drépanocytaire au Congo. Publications médicales Africaines, 131, 12-16.
|
[31]
|
Elira Dokekias, A. and Nzingoula, S. (2001) Profil du sujet drépanocytaire homozygote après l’age de 30 ans. Médecine d'Afrique Noire, 48, 411-418.
|